Antifilarial agents
Nisha Mathew, Muthuswami Kalyanasundaram
Abstract
Nisha Mathew, Muthuswami Kalyanasundaram
Abstract
Lymphatic filariasis and river blindness (onchocerciasis) are two important tropical diseases caused by infections with filarial nematodes, resulting in considerable morbidity. Onchocerciasis is caused by infection with the nematode worm Onchocerca volvulus, which is transmitted by blackflies. Lymphatic filariasis is caused by infection with the parasitic nematodes, Wuchereria bancrofti, Brugia malayi and B. timori transmitted by mosquito vectors. Onchocerciasis is presently treated with ivermectin, while the drugs used for lymphatic filariasis are diethylcarbamazine and ivermectin in combination with albendazole. None of these is effective in completely killing the long-lived adult worms (macrofilariae) and, therefore, treatments are aimed at reducing transmission and pathology. New drugs that affect new molecular targets are essential to improve treatment and control by killing the adult filarial worms. An exhaustive review on antifilarial drug development is presented here.
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Lymphatic filariasis and river blindness (onchocerciasis) are two important tropical diseases caused by infections with filarial nematodes, resulting in considerable morbidity. Onchocerciasis is caused by infection with the nematode worm Onchocerca volvulus, which is transmitted by blackflies. Lymphatic filariasis is caused by infection with the parasitic nematodes, Wuchereria bancrofti, Brugia malayi and B. timori transmitted by mosquito vectors. Onchocerciasis is presently treated with ivermectin, while the drugs used for lymphatic filariasis are diethylcarbamazine and ivermectin in combination with albendazole. None of these is effective in completely killing the long-lived adult worms (macrofilariae) and, therefore, treatments are aimed at reducing transmission and pathology. New drugs that affect new molecular targets are essential to improve treatment and control by killing the adult filarial worms. An exhaustive review on antifilarial drug development is presented here.
Key concepts: Lymphatic filariasis, Onchocerciasis, Ivermectin, Brugia malayi, Onchocerca volvulus, Diethylcarbamazine, Wuchereria bancrofti, Filariasis